Deals Rumor Mill: Fosun, UnitedHealth, Niu

By Adam Rhodes (July 19, 2018, 6:33 PM EDT) -- A Fosun International subsidiary is mulling a deal to float Gland Pharma, according to an early Thursday report from Bloomberg. The report notes that the Indian drugmaker could raise roughly $500 million in a public offering. Citing anonymous sources, the outlet reported that Shanghai Fosun Pharmaceutical (Group) Co. is talking to possible advisers about the offering, though deliberations are at an early stage. The report comes after the unit said in September that it would buy a nearly 75 percent stake in Gland for more than $1 billion....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!